http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190085767-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb6372dde89a8ac6af866c273e9f3f8f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate | 2018-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3311caae4cff269820cad3f64243edf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754b24300699aaff831f439e3d77470d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_361f5e0f7eb9b98809919e41324b4f1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bee08a9f5eeda314b982e577796663f2 |
| publicationDate | 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190085767-A |
| titleOfInvention | Composition for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising extract or fraction of Hydnocarpi semen or compound derived from Hydnocarpi semen extract as effective component |
| abstract | The present invention relates to a composition for preventing, ameliorating or treating hyperlipidemia or hyperlipidemia-related metabolic disorders comprising as an active ingredient a compound isolated from the extracts of the genus Majora, fractions thereof, The compounds isolated from the fractions or the extracts from Zygomaster extract not only inhibit the activity of xanthine oxidase but also have an effect of reducing the content of uric acid in the serum. In addition, since the active ingredient is derived from a natural product and is safe, it can be effectively used as a health functional food or medicine for preventing, ameliorating or treating hyperlipidemia or hyperlipidemia-related metabolic disorders. |
| priorityDate | 2018-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.